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Background: Previous research has shown that Ramadan fasting has beneficial effects on cardiovascular risk factors,
however there are controversies. In the present study, the effect of Ramadan fasting on cardiovascular risk factors
has been investigated.
Method: This is a prospective observational study that was carried out in a group of patients with at least one
cardiovascular risk factor (including history of documented previous history of either coronary artery disease (CAD),
metabolic syndrome or cerebro-vascular disease in past 10 y). Eighty two volunteers including 38 male and 44
female, aged 29–70 y, mean 54.0 ± 10 y, with a previous history of either coronary artery disease, metabolic
syndrome or cerebro-vascular disease were recruited. Subjects attended the metabolic unit after at least 10 h
fasting, before and after Ramadan who were been fasting for at least 10 days. A fasting blood sample was
obtained, blood pressure was measured and body mass index (BMI) was calculated. Lipids profile, fasting blood
sugar (FBS) and insulin, homocysteine (hcy), high-sensitivity C-reactive protein (hs-CRP) and complete blood count
(CBC) were analyzed on all blood samples.
Results: A significant improvement in 10 years coronary heart disease risk (based on Framingham risk score) was
found (13.0 ± 8 before Ramadan and 10.8 ±7 after Ramadan, P <0.001, t test).There was a significant higher HDL-c,
WBC, RBC and platelet count (PLT), and lower plasma cholesterol, triglycerides, LDL-c, VLDL-c, systolic blood
pressure, body mass index and waist circumference after Ramadan (P <0.05, t test). The changes in FBS, insulin,
Homeostasis Model Assessment Insulin Resistance (HOMA-IR), hcy, hs-CRP and diastolic blood pressure before and
after Ramadan were not significant (P >0.05, t test).
Conclusions: This study shows a significant improvement in 10 years coronary heart disease risk score and other
cardiovascular risk factors such as lipids profile, systolic blood pressure, weight, BMI and waist circumference in
subjects with a previous history of cardiovascular disease.
Keywords: Ramadan, Fasting, hs-CRP, Homocysteine, FBS, Insulin resistance, Cardiovascular diseases, Risk factorsIntroduction
Ramadan is a month for Muslims during which they abstain
from eating, drinking and smoking from dawn to sunset.
During month of Ramadan there are changes in the
quality of food and eating patterns. It might be due to
the consumption of more carbohydrates and sweet
foods, mainly in the form of two large meals at dawn* Correspondence: norouzya@mums.ac.ir
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reproduction in any medium, provided the orand sunset [1]. It has been established that a given nutri-
ent ingested at an unusual time can induce different
metabolic effects [2]; however, the physiological changes
in Ramadan are not well known.
Cardiovascular diseases are the leading cause of death in
the world [3]. Fasting during Ramadan is essentially a radical
change in lifestyle for the period of one lunar month that
may affect cardiovascular risk in patients with coronary ar-
tery disease (CAD) and cerebro-vascular disease (CVD) [4,5].
The most common risk factors associated with
increased risk of atherosclerotic heart disease or strokel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and haemostatic factors, hypertension and smoking [6].
Lipids profile are affected by factors such as changes
in the dietary habits, using different dietary fats,
increased consumption of refined sugar, and reduced
physical activity [7].
Many studies reported a significant reduction in type 2
diabetic patients' weight during Ramadan [8,9], some
other reported a non-significant reduction in weight of
these patients [10]. Bouguerra et al. showed Ramadan
fasting has a moderate effect on glycaemia and lipopro-
tein levels in type 2 diabetic patients when previous
metabolic control was quite good; but fasting induced
more deterioration when previous control was poor [9].
Although, another study in Iran showed a deterioration
of glycaemic control after Ramadan fasting in Type 2
diabetic patients that was more evident in patients using
oral hypoglycaemic medication than diet-controlled
patients [11]. Shariatpanahi et al. showed that the com-
bined change in the number and timing of meals and
portioning of the entire intake into only two meals per
day may increase insulin sensitivity in Ramadan [8].
Homocysteine (Hcy) is a well-known mixed amino acid,
intermediary on the metabolic pathway between methio-
nine and cysteine [12]. Mild to moderate elevation of
plasma hcy concentration has been known as carrying
an increased risk for the development of atherosclerotic
vascular disease [13]. Hyperhomocysteinemia is thus an
independent risk factor for atherosclerosis, and impaired
arterial endothelial function is detectable in healthy
adults with hyperhomocysteinaemia [13].
High-sensitivity C-reactive protein (hs-CRP), a plasma
inflammation marker, has been known to play a role in
the development of cardiovascular diseases and is consid-
ered as a biomarker that is useful in the prediction of early
cardiovascular risk [14]. Several prospective epidemio-
logical studies have demonstrated a consistent relationship
between higher C-reactive protein (CRP) levels and
increased risk of cardiovascular events, including myocar-
dial infarction, stroke, and cardiovascular death [15,16].
CRP may reflect a greater burden of atherosclerosis or al-
ternatively may identify a high-risk atherosclerosis pheno-
type with an active inflammation and atherosclerotic
plaque that is vulnerable to rupture [17,18].
Fasting is not meant to create excessive hardship for
individuals who are not able to do that, the Islamic prac-
tice exempts many people from fasting, including those
who are ill and fasting is harmful for them [19]. One of
the common questions for patients with a history of car-
diovascular disease is whether it is safe for them to fast
during Ramadan. Yet, studies on the effects of Ramadan
fasting on blood lipids, blood pressure, anthropometric
parameters and other cardiovascular risk factors are
scarce, and have given inconclusive results [9,10,20].In current research, the effect of Ramadan fasting on
cardiovascular risk factors including biochemical indices,




This was a prospective observational study that was car-
ried out in a group of patientswith at least one cardio-
vascular risk factor (including history of documented
previous history of either coronary artery disease (CAD),
metabolic syndrome or cerebro-vascular disease in past
10 y). Subjects' risk factors were compared before and
after Ramadan month to see the effects of fasting on it.
This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all proce-
dures involving human subjects were approved by the
Research Ethics Committee of Mashad University of
Medical Sciences (approval number 87224). Written
informed consent was obtained from all subjects. This
study was conducted in the month of Ramadan during
September/October 2008 in city of Mashad, Iran.
Volunteers were recruited from outpatient cardiology
clinics in Imam Reza and Ghaem teaching hospitals via
poster advertisement or direct invitation. Inclusion cri-
teria were male and female between 29 and 70 years old
with a history of documented previous history of either
coronary artery disease (CAD), metabolic syndrome or
cerebro-vascular disease in past 10 y.76 patients were
taking medications including 52 patients on antihyper-
tensive agents,47 patients onstatins, 26patients on oral
antidiabetic medications including metformin and sul-
phonyleureas and 46 patients on antiplatelet aggregation
agents. Six patients did not take any medications.
Diagnosis of cardiovascular disease was based of cardi-
ologist judgment.
Exclusion criteria were pregnant and lactating women,
subjects with the age of below 18 y old and those who
fasted for less than 10 d. Subjects were nonsmoker and
volunteers with any type of acute inflammation (hs-CRP
>5) were excluded. One hundred and one subjects parti-
cipated in the first part of the study; however, 82 sub-
jects completed the study. Seventeen patients were
excludedbecause of fasting for less than 10 d and 2 sub-
jects withdrew their consent for personal reasons.
Past medical history, drug and smoking history were
obtained prior the study.
Blood sampling and data gathering
Subjects attended the metabolic unit after 10–12 h fast-
ing, in two stages; between 7 d before and 2 first days of
starting Ramadan and from the 27th of Ramadan till 6 d
after end of this month. An 8 mL fasting blood sample
was collected from the median cubital vein by using
Nematy et al. Nutrition Journal 2012, 11:69 Page 3 of 7
http://www.nutritionj.com/content/11/1/69vacuum sampling method. The blood samples were ana-
lyzed in an University affiliated laboratory.
Systolic and diastolic blood pressures were measured
in duplicate by sphygmomanometers (Omron M3, M4,
Omron Corporation, the Netherlands). If difference be-
tween two measurements was more than 5%, a third
reading was performed and average of two near readings
was considered as mean blood pressure. Food frequency
questionnaire (FFQ) was completed in both stages before
and after Ramadan at the same Ramadan in the matched
BMI from the control group.
Anthropometric parameters such as height, body
weight and waist circumference were measured in both
phases. Body mass index (BMI) was calculated as body
weight (kg) divided by squared height in meters (m2).
Height and weight were measured, using standardized
procedures. Height was measured using a portable stadi-
ometer (OTM, Tehran, Iran). Height measurement was
taken to the nearest 0.1 cm, without shoes, with the sub-
ject stretching to the maximum height and the head
positioned in the Frankfort plane. Weight was measured
using Rassa weight scale (Rassa, Tehran, Iran) to the
nearest 100 g with subjects removing shoes and in light
clothing. Waist circumference was measured to the
nearest 0.1 cm at the mid-point between the lower rib
and the upper margin of the iliac crest [21] in a horizon-
tal plane by using a no stretching tape with an insertion
buckle at one end.
Assays
Lipids profile, fasting blood sugar (FBS), fasting insulin,
hs-CRP, hcy and complete blood count (CBC) were ana-
lyzed using standard methods. Homocysteine measure-
ment was being performed on blood plasma and the
other variables on blood serum.
Triglyceride (TG) and cholesterol were measured
byGPO-PAP and CHOD-PAP methods respectively (Par-
sazmun kit, Karaj, Iran, for both). The direct method
was used for determiningthe HDL and LDL by Human
kits (Human Gesellschaft fur Biochemica und Diagnostica
GmbH, Max-Planck-Ring 21 – D-65205 Wiesbaden –
Germany) and fasting blood glucose was measured by
glucose-oxidize, GOD-PAP method [22](Parsazmun kit,
Karaj, Iran). Total hcy measurement was performed with
immunoturbidometry, based on assays to co-substrate
conversion product [23,24] (Demeditec Diagnostic
GmbH, Lise-Meitner-strabe 2, D-24145 Kiel Germany).
Insulin was measured, using radioimmunoassay methods
(ELISA) with IRMAkit (Immunotecha.s. Prague, Czech
Republic). Hs-CRP concentration was measured by
immunoturbidometry method by auto analyzer [25]
(Prestige 24i, Tokyo Boeki, Japan). Insulin resistance was
estimated from the homeostasis model assessment of in-
sulin resistance (HOMA-IR) originally described byMatthews et al. [26] as calculated from the following
equation:
Fasting insulin concentration μU=mLð Þ½
 fasting glucose concentration mmol=Lð Þ=22:5
[22] Cell blood counts were measured by KX-21 N
Sysmexautoanalyser system (Sysmex Shanghai Ltd,
Lujiazu, China).
Framingham coronary heart disease risk score was
used to calculate the risk of CAD [27].
Data analysis
The Kolmogorov-Smirnov test was performed to assess
the normal distribution. Differences between results
were analyzed, using paired samples t test for normally
distributed parameters and Wilcoxon Signed Ranks test
for not normally distributed parameters (LDL, TG, FBS,
HOMA-IR and hs-CRP). Relationship between dichotom-
ous and quantitative variables was assessed by independ-
ent sample ttest and correlation between quantitative and
quantitative variables was evaluated by Pearson’s correl-
ation. Two-wayrepeated measures ANOVA were used to
assess interactions among variables seem to be effective
on parameter differences (P <0.15 in Pearson’s correlation
or independent sample t test) on variables before and
after Ramadan. Quantitative data were expressed as the
mean± SD for all parameters. Statistical significance was
considered at P <0.05 for all tests. Relationship among
cholesterol serum level and existing CAD, using statin
family medication and hypertension (based on history)
were evaluated by using two-way repeated measures
ANOVA. These statistical analyses were conducted by
using SPSS statistical software (version 11.5, SPSS Inc.
Chicago, IL).
Results
Duration of daily fasting during Ramadan 2008 was be-
tween 14 h and 42 minin first day and 13 h and 35 min
in last day in Mashad, Iran. The mean days subjects
fasted in this study was 26.3 ± 5 (range 10–35 d).
Eighty two volunteers including 38 male and 44 fe-
male, age 29–70 y, mean 54.0 ± 10 y, with a previous his-
tory of either coronary artery disease (CAD) (60.9%),
metabolic syndrome (67%) or cerebro-vascular disease
(2.4%) in past 10 y completed the study. Twenty eight
percent of them (23 volunteers) were suffering from
both CAD and metabolic syndrome.
10 years coronary heart disease risk
This study shows a significant improvementin 10 years
coronary heart disease risk, based on Framingham risk
score (13.0 ± 8 before Ramadan and 10.8 ±7 after Ram-
adan, P <0.001, t test).
Table 2 Effect of Ramadan fasting on some clinical and
biological parameters before and after Ramadan (n =65
for hs-CRP and 82 for rest)
Biochemical variables Before Ramadan After Ramadan p-values
x  SD3 x  SD3
FBS1(mmol/l) 124.7 ± 48 128.1 ± 54 0.327
insulin (μU/mL) 12.4 ± 9.5 11.8 ± 7.6 0.583
HOMA.IR (μUmol/l2) 3.8 ± 3 3.6 ± 3 0.093
Hcy2(μmol/l) 10.5 ± 3.8 11.5 ± 3.9 0.065
hs-CRP ( mg/L) 1.0 ± 1 0.9 ± 1 0.160
1FBS, fasting blood sugar.
2Hcy, homocysteine.
3SD= standard deviation.
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The values of total cholesterol, triglycerides, VLDL-c,
LDL-c, cholesterol/HDL and LDL/HDL ratio were signifi-
cantly decreased (P=0.02 for cholesterol and P <0.001 for
rest, Wilcoxon test for triglycerides and LDL, and paired t
test for rest) and HDL-c increased significantly (P <0.001,
paired t test) after Ramadan fasting (Table 1).
It appears that there was no significant effects of CAD,
hypertension and taking statin drugs on cholesterol mean
level variations before and after Ramadan (P=0.12,
P=0.09 and P= 0.71 respectively). Effect of Ramadan fast-
ing on cholesterol was independent of existing CAD,
hypertension and taking statins (P=0.04, ANOVA).
Blood pressure
There was a significant decrease in systolic blood pres-
sure (132.9 ± 16 mmHg,129.9 ± 17 mmHg, P= 0.03, paired
t test). Although, no significant change in diastolic blood
pressure was found (80.2 ± 9, 78.6 ± 11 mmHg, P= 0.14,
paired t test).
FBS, insulin, HOMA-IR, homocysteine, hs-CRP
As it is shown in Table 2, FBS, insulin, HOMA-IR, hcy
and hs-CRP concentrations showed no significant differ-
ence after Ramadan fasting (P= 0.33, P= 0.58, P= 0.76,
P= 0.06 and P= 0.07 respectively, paired t test for insulin
and hcy and Wilcoxon test for rest).
Anthropometric parameters
Body weight, BMI and waist circumference reduced sig-
nificantly after Ramadan fasting (73.5 ± 13, 71.7 ± 13 kg,
28.4 ± 4, 27.7 ± 4 kg/m2 and98.3 ± 9, 96.7 ± 9 cm respect-
ively and P <0.001, paired t test).
Hematological parameters
Table 3 illustrates the values regarding hematological
parameters before and after Ramadan. The mean con-
centrations of all these parameters (except hemoglobin
and Hematocrit) showed significant changes when com-
pared before and after Ramadan (P= 0.25 and P= 0.32Table 1 Effect of Ramadan fasting on lipids profile before
and after Ramadan (n =82)
Biochemical variables Before Ramadan After Ramadan p-values
x  SD3 x  SD3
Cholesterol(mg/dL) 193.4 ± 51 184.3 ± 42 0.023
Triglycerides (mg/dL) 224.8 ± 129 182.9 ± 112 0.000
HDL-c ( mg/dL ) 43.0 ± 9 47.9 ± 8 0.000
Cholesterol/HDL(ratio) 4.5 ± 1 3.9 ± 1 0.000
VLDL-c (mg/dL ) 38.1 ± 14 33.8 ± 17 0.000
LDL-c (mg/dL ) 109.96 ± 46 96.83 ±35 0.000
LDL/HDL (ratio) 2.5 ± 0.8 2.0 ± 0.6 0.000
3SD= standard deviation.respectively, paired t test). There was a significant higher
WBC, RBC, platelet count (PLT) (P= 0.01, P <0.001,
P <0.001 respectively, paired t test), and significant lower
MCV and MCH (P <0.001, paired t test) after Ramadan.
There was no significant correlation among number of
fasting days and studied parameters in this study.
Food records
FFQ results are shown in Table 4. The data show a sta-
tistically non-significant reduction in energy and other
macronutrients intake during fasting in month of
Ramadan.
Discussion
This study shows a significant improvement in 10 years
coronary heart disease risk, based on Framingham risk
score.To the best of our knowledge, there was no similar
study among cardiovascular patients to assess the effect
of Ramadan fasting on cardiovascular risks. Most of the
studies evaluated changes of some cardiovascular risk
factors among metabolic syndrome, diabetic, hyperlipid-
emic patients and or healthy adults.
There was a significant higher HDL-c and lower chol-
esterol, triglycerides, LDL-c, VLDL-c levels, cholesterol/Table 3 Effect of Ramadan fasting on hematological
factors before and after Ramadan (Mean values with
standard deviation) (n = 82)
Hematological factors Before Ramadan After Ramadan p-values
x  SD3 x  SD3
WBC (1000/μl) 6.6 ± 1.5 6.9 ± 1.5 0.011
RBC (mil/μl) 4.7 ± 0.3 4.9 ± 0.4 0.000
HGB1(g/dL) 13.6 ± 1.2 13.7 ± 1.0 0.254
MCV (fl) 87.6 ± 5.0 83.7 ± 4.2 0.000
MCH (pg) 28.8 ± 2.1 27.9 ± 1.8 0.000




Table 4 Effect of Ramadan fasting on energy and nutrient
intake of control group before and after Ramadan (Mean
values with standarddeviation) (n =82)
Consumption Before Ramadan After Ramadan p-values
x  SD1 x  SD1
Energy (kcal) 2588.6 ±1485 2449.3 ± 1179 0.337
Carbohydrates(g/day) 327.8 ±179 321.0 ± 171 0.746
Protein (g/day) 96.7 ± 59 85.4 ± 45 0.071
Fat (g/day) 100.0 ± 64 92.6 ± 42 0.263
Fiber(g/day) 22.3 ± 14 20.2 ± 11 0.180
1SD= standard deviation.
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study. In Helsinki Heart Study a 10% reduction in TC,
LDL-c (11%), 35% decrease in triglycerides and 11% in-
crease in HDL-c after the intervention with pharmaco-
logical agent was associated with a 34% reduction in
cardiovascular event [28]. A 2 unit increment of TC/
HDL adds an excess of 68% to CHD risk [27,29]. Our
study demonstrates significant improvement (−0.6) in
TC/HDL and other lipids profile after Ramadan fasting
which might be associated with a nearly 20% reduction
in the risk of CHD.
A reduction in cholesterol [30,31], and triglycerides
levels [30-32], has been reported in previous studies;
however, The result of some other reports showed no
significant changes in cholesterol [1,12,32-34] and trigly-
cerides [1,2,33,34]. In a study in Kuwait on sixteen sed-
entary healthy adult males, there was no significant
change in TG level after Ramadan [33]. This discrepancy
was possibly due to small sample size or different Ram-
adan diet pattern in Kuwait study which includes more
sweetened foods. Also, there are some reports about
increased cholesterol [10,35] and triglycerides [10] after
Ramadan fasting. There is a tendency for higher simple
carbohydrate consumption during Ramadan [36].
Improvement in HDL-c has been shown in somestu-
dies after fasting in Ramadan [2,30,31,34], while some
other studies reported no significant change [1,32] or de-
crease [9,10] in HDL-c after Ramadan.
Significant decline in LDL-c has been reported in some
studies after Ramadan fasting[2,30,31]. Also, no significant
change [1,12,32,34] or significant increase [9,10,35] of
LDL-c has been reported in other investigations.
It seems that the effect of Ramadan fasting on serum
lipid levels may be closely related to the dietary habits
and other life style changes [2,7].
There were significant decrease in systolic blood pres-
sure and no significant change in diastolic blood pres-
sures after Ramadan fasting in the present study.
However, there are reports about significant decrease
[1], no significant change [9,20,30,35] and significant in-
crease [33] in systolic blood pressure.There was no significant change in FBS, fasting insulin
and insulin-resistance (HOMA-IR) after Ramadan fast-
ing in the present study. Some studies showed no signifi-
cant changes in the serum level of glucose [1,33,35].
While, the others reported higher [9] or lower [2,10,32]
FBS after Ramadan fasting. These controversies may be
explained by different food habits, amount of calorie in-
take [30], the number of fasting days, period of daily
fasting, time of sampling, genetic tendency and daily ac-
tivity in different reports. There is a report about signifi-
cant increase in insulin sensitivity (1/HOMA IR) in
subjects with the metabolic syndrome [8] and significant
decrease in insulin and insulin resistance among men
patients with type II diabetes after Ramadan fasting [35].
The lack of improvement in HOMA-IR or FBS despite
reduction in body weight may be due to decrease in total
body water content instead of body fat content after
Ramadan fasting.
The value of hcy level did not change significantly
after Ramadan in the present study. Although, Aksun-
gar's study has been reported significant decrease in hcy
after Ramadan fasting in 40 healthy volunteers [12].
Body weight and BMI decreased significantly in the
present study (−1.4 kg and −0.7 kg/m2 respectively,
P <0.001). Most reports are similar to these results
[31,32]. Although, there are some reports about non-
significant changes in body weight [37] and BMI [37,38]
after Ramadan fasting.
In another study, no change was seen concerning an-
thropometric parameters [7].Limitations
There was no control group in this study. Pre Ramadan
sampling in Ramadan was performed in the morning
after an overnight fasting, while post Ramadan blood
sampling was performed in the afternoon, after at least
10 h fasting during day time. This difference in the time
of blood sampling was inevitable to have at least 10 h
fasting. As the circadian rhythms of nutrition-related
biological variables shows some degree of changes dur-
ing Ramadan [39], there might be concerns about
amount of daily activities or circadian rhythm of hor-
mones like cortisol which might affect FBS levels. In the
present study, we had only two measurements during
the study, possibly evaluation in the middle of the
month and after a time after Ramadan would reveal
more details and shows us the trend of changes. Level of
physical activity of the study population was not mea-
sured in this study. FFQ was completed for a control
group not our subjects as this study was part of the big-
ger study that food data were completed as a separate
study for a 500 volunteers to assess food pattern changes
in Ramadan.
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habitual changes controlled with matched control group
is warranted.
Conclusion
This study shows a significant improvement in10 years
coronary heart disease risk score and other cardiovascular
risk factors such as weight, BMI and waist circumference
in subjects with a previous history of cardiovascular disease
after an average of 26 d fasting during month of Ramadan.
Result from this study suggested that Ramadan fasting may
be useful to improve CVD risk factors.
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